140
Participants
Start Date
March 7, 2019
Primary Completion Date
October 23, 2019
Study Completion Date
October 23, 2019
AD036 Dose 1
AD036 Dose 1 oral capsule administered before sleep
AD036 Dose 2
AD036 Dose 2 oral capsule administered before sleep
AD036 Dose 3
AD036 Dose 3 oral capsule administered before sleep
Placebo
Placebo oral capsule administered before sleep
Clinilabs Drug Development Corporation, New York
The Center for Sleep and Wake Disorders, Chevy Chase
Norton Clinical Research Group, Louisville
CTI Clinical Research Center, Cincinnati
Northwestern University, Chicago
Sleep Medicine & Research Center, St. Luke's Hospital, Chesterfield
Preferred Research Partners, Inc., Little Rock
Sleep Therapy & Research Center, San Antonio
Pulmonary Associates, Glendale
Santa Monica Clinical Trials, Santa Monica
SDS Clinical Trials, Inc., Santa Ana
Stanford Sleep Medicine, Redwood City
Lead Sponsor
Apnimed
INDUSTRY